Andrew Hinson

Andrew Hinson has a long history of work experience in the medical field. Andrew began their career as a student at the University of Cincinnati in 1982. In 1993, they became a Senior Manager at Procter & Gamble Pharmaceuticals. In 2002, they took a role as Director of Clinical Development at Anges MG, Inc. Andrew then moved to LoneStar Heart, Inc. in 2004, where they served as Vice President of Clinical & Regulatory. In 2016, they became a Medical Consultant for Clin2Reg Consulting and in 2021, they joined the Board of Directors at BioVentrix. Andrew also serves as a Scientific Advisory Board Member and Chair of Corporate Governance Committee at BioLife Solutions, Inc.

Andrew Hinson received their B.S. in Biochemistry from the University of Cincinnati in 1986. Andrew also obtained a Corporate Governance Certificate from UCLA Anderson School of Management in September 2015 and RDCS, RVT from ARDMS in August 1986. Andrew attended the University of Maryland, but did not obtain a degree.